CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 70 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44 | -35.3% | 102,884 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $68 | -99.9% | 102,884 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $88,000 | +54.4% | 102,884 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $57,000 | -50.0% | 102,884 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $114,000 | -35.6% | 102,884 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $177,000 | -44.0% | 102,884 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $316,000 | -21.2% | 102,884 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $401,000 | +39.7% | 102,884 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $287,000 | -8.9% | 102,884 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $315,000 | -49.7% | 102,884 | 0.0% | 0.01% | -56.2% |
| Q3 2020 | $626,000 | +3.0% | 102,884 | 0.0% | 0.02% | -11.1% |
| Q2 2020 | $608,000 | +122.7% | 102,884 | 0.0% | 0.02% | +100.0% |
| Q1 2020 | $273,000 | -2.5% | 102,884 | 0.0% | 0.01% | +28.6% |
| Q4 2019 | $280,000 | – | 102,884 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
| BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
| EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
| Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
| CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
| Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
| Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
| Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
| AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
| Broderick Brian C | 32,919 | $377,000 | 0.13% |